Bigul

Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 22Nd June, 2024

Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 22nd June, 2024 at the Registered Office of the Company which commenced at 02:00 P.M. and concluded at 02:30 P.M. has considered and approved Allotted 1,13,00,000 (One Crore and Thirteen Lakhs Thousand) fully paid-up Equity shares of face value of Rs. 10.00/- (Rupees Ten Only) per share, at a price of Rs. 17/- (Rupees Seventeen Only) per share, aggregating to Rs. 19,21,00,000/- (Rupees Nineteen Crore Twenty One Lakhs Only) for cash consideration to the person(s)/ entity(ies) belonging to Non-Promoter category on a preferential basis in accordance with provisions of Chapter V of SEBI (ICDR) Regulations, 2018, as mentioned in 'Annexure - I'.
22-06-2024
Bigul

Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 27Th May, 2024

Pursuant to Regulations 30 (6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 27th May, 2024, at the registered Office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 04:00 P.M. and concluded at 8:00 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report.
27-05-2024
Bigul

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 27Th May, 2024

Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company will be held on Monday, 27th May, 2024 at 4:00 P.M. at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380060, to consider and approve the Audited Financial Results of the Company for the Half-year and year ended on 31st March, 2024 along with Auditor's Report.
20-05-2024
Bigul

Evoq Remedies Ltd - 543500 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024

Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the financial year ended on 31st March, 2024
30-04-2024
Bigul

Evoq Remedies Ltd - 543500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for the Quarter ended on 31st March, 2024.
15-04-2024
Bigul

Evoq Remedies Ltd - 543500 - Clarification Sought On Significant Movement In Price

Clarification Sought on Significant movement in price.
11-04-2024
Bigul

Evoq Remedies Ltd - 543500 - Clarification sought from Evoq Remedies Ltd

The Exchange has sought clarification from Evoq Remedies Ltd on April 4, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
04-04-2024
Next Page
Close

Let's Open Free Demat Account